Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mirro

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Unexpectedly severe toxicity from intensive early treatment of childhood lymphoblastic leukemiaG K Rivera, W E Evans, D K Kalwinsky, et al.
Toxicologic Pathology|December 24, 1998
Vacuolation in renal tubular epithelium of Cd-1 mice: an incidental findingR C Johnson, B J Dovey-Hartman, J Syed, et al.
Applied Clinical Informatics|March 1, 2019
Erratum to: Providing Patients with Implantable Cardiac Device Data through a Personal Health Record: A Qualitative StudyCarly N Daley, Elizabeth M Chen, Amelia E Roebuck, et al.
Haematology and Blood Transfusion|January 1, 1987
Limiting toxicities during intensified remission induction chemotherapy for childhood acute lymphocytic leukemiaG K Rivera, E Kovnar, C H Pui, et al.
Lancet (London, England)|January 22, 1991
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapyG K Rivera, S C Raimondi, M L Hancock, et al.
The New England Journal of Medicine|July 20, 1989
Secondary acute myeloid leukemia in children treated for acute lymphoid leukemiaC H Pui, F G Behm, S C Raimondi, et al.
Toxicologic Pathology|June 19, 2004
The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeysPatricia E Losco, Ellen W Evans, Stephen A Barat, et al.
Leukemia Research|January 1, 1986
Unfavorable presenting clinical and laboratory features are associated with CALLA-negative non-T, non-B lymphoblastic leukemia in childrenC H Pui, D L Williams, S C Raimondi, et al.
Leukemia|October 6, 2000
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.
Journal of Hematotherapy|August 1, 1997
The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrowS M Neudorf, W Rybka, E Ball, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Unexpectedly severe toxicity from intensive early treatment of childhood lymphoblastic leukemiaG K Rivera, W E Evans, D K Kalwinsky, et al.
Toxicologic Pathology|December 24, 1998
Vacuolation in renal tubular epithelium of Cd-1 mice: an incidental findingR C Johnson, B J Dovey-Hartman, J Syed, et al.
Applied Clinical Informatics|March 1, 2019
Erratum to: Providing Patients with Implantable Cardiac Device Data through a Personal Health Record: A Qualitative StudyCarly N Daley, Elizabeth M Chen, Amelia E Roebuck, et al.
Haematology and Blood Transfusion|January 1, 1987
Limiting toxicities during intensified remission induction chemotherapy for childhood acute lymphocytic leukemiaG K Rivera, E Kovnar, C H Pui, et al.
Lancet (London, England)|January 22, 1991
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapyG K Rivera, S C Raimondi, M L Hancock, et al.
The New England Journal of Medicine|July 20, 1989
Secondary acute myeloid leukemia in children treated for acute lymphoid leukemiaC H Pui, F G Behm, S C Raimondi, et al.
Toxicologic Pathology|June 19, 2004
The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeysPatricia E Losco, Ellen W Evans, Stephen A Barat, et al.
Leukemia Research|January 1, 1986
Unfavorable presenting clinical and laboratory features are associated with CALLA-negative non-T, non-B lymphoblastic leukemia in childrenC H Pui, D L Williams, S C Raimondi, et al.
Leukemia|October 6, 2000
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.
Journal of Hematotherapy|August 1, 1997
The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrowS M Neudorf, W Rybka, E Ball, et al.
Pageof 19